Nephrogen raised $0.22 million to engineer AI-driven gene delivery vectors for kidney and pancreatic diseases, enabling researchers and clinicians to advance genomic therapies and improve patient outcomes.
All entries for: Nephrogen
September 1, 2025
Nephrogen
Investment
Nephrogen raised an undisclosed amount to engineer AI-driven gene delivery vectors for kidney and pancreatic diseases, enabling researchers and clinicians to advance genomic therapies and improve patient outcomes.
Disease Area: Rare Diseases
